Back
iShares US Home Construction ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
42
ITB
iShares US Home Construction ETF
Last Price:
$98.22
Seasonality Move:
2.21%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$767.87
Seasonality Move:
12.13%
Sell
42
iShares US Home Construction ETF (ITB)
is a Sell
Is iShares US Home Construction ETF a Buy, Sell or Hold?
-
The current iShares US Home Construction ETF [ITB] share price is $98.18. The Score for ITB is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ITB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $767.96. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITB Stock Price Chart
What is iShares US Home Construction ETF's stock price today?
-
The iShares US Home Construction ETF share price today is $98.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITB is experiencing slight selling pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $767.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 41.04 | Sell |
| Chaikin Money Flow: | -870227 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (96.76 - 103.76) | Sell |
| Bollinger Bands (100): | (99.29 - 109.97) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 142.35 | Buy |
| Relative Strength Index (14 RSI): | 64.22 | Buy |
| Chaikin Money Flow: | 1264020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (712.01 - 765.19) | Buy |
| Bollinger Bands (100): | (552.57 - 698.59) | Buy |
ITB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.1 | Sell |
| 20-day SMA: | 101.7 | Sell |
| 50-day SMA: | 100.78 | Sell |
| 200-day SMA: | 99.12 | Sell |
| 8-day EMA: | 100.44 | Sell |
| 20-day EMA: | 100.84 | Sell |
| 50-day EMA: | 101.49 | Sell |
| 200-day EMA: | 102.14 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 747.47 | Buy |
| 20-day SMA: | 745.1 | Buy |
| 50-day SMA: | 678.03 | Buy |
| 200-day SMA: | 600.91 | Buy |
| 8-day EMA: | 400.86 | Buy |
| 20-day EMA: | 196.11 | Buy |
| 50-day EMA: | 85.47 | Buy |
| 200-day EMA: | 22.33 | Buy |
iShares US Home Construction ETF Earnings Growth & ITB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
iShares US Home Construction ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||